# Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)

> **NCT05138263** · — · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 640 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05138263
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05138263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05138263, "Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2 (KBASE2)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05138263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*